Clinical trial
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142
Study timeline
Study start (actual)2020-04-14Date precision: day
Registry last updated2024-12-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Optic Neuritisunresolved
Transverse Myelitisunresolved
Acute Disseminated Encephalomyelitisunresolved
Multiple Sclerosisunresolved
Neuromyelitis Optica Spectrum Disorderunresolved
Anti-NMDAR Encephalitisunresolved
Hashimoto Encephalitisunresolved
CNS Vasculitisunresolved
CNS Sarcoidosisunresolved
CNS Lupusunresolved
Rasmussen Encephalitisunresolved
Interventions
Sponsors & collaborators
University of Bernlead sponsor
Schweizerische Multiple Sklerose Gesellschaftcollaborator
Insel Gruppe AG, University Hospital Berncollaborator
Novartiscollaborator
Anna Mueller Grocholski-Stiftungcollaborator
Biogencollaborator
Roche Pharma (Switzerland) Ltdcollaborator
Fondation Johanna Dürmüller-Bolcollaborator
Kantonsspital Aaraucollaborator
University Children's Hospital Baselcollaborator
Ente Ospedaliero Cantonale, Bellinzonacollaborator
Kantonsspital Graubündencollaborator
University Hospital, Genevacollaborator
Centre Hospitalier Universitaire Vaudoiscollaborator
Ostschweizer Kinderspitalcollaborator
Kantonsspital Winterthur KSWcollaborator
Sanoficollaborator
Hôpital Fribourgeoiscollaborator
University Children's Hospital, Zurichcollaborator
Luzerner Kantonsspitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05017142 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.